MAPK8 and Parkinson disease: Notably, treatment with the JNK inhibitor SP600125 reduced dopaminergic neuronal apoptosis and preserved motor performance in MPTP-treated mice, underscoring the pivotal contribution of JNK signaling to PD pathogenesis [83].